Financial Gravity Asset Management, Inc. Ani Pharmaceuticals Inc Transaction History

Financial Gravity Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$50.28 - $64.61 $2,664 - $3,424	-53 Reduced 98.15%	1 $0
Q2 2023 Aug 08, 2023	BUY	$37.29 - $53.83 $2,013 - $2,906	54 New	54 $858,000
Q4 2019 Feb 28, 2020	SELL	$55.65 - $79.83 $25,599 - $36,721	-460 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$64.7 - $85.39 $2,329 - $3,074	36 Added 8.49%	460 $34,000
Q2 2019 Jul 26, 2019	SELL	$67.77 - $82.2 $23,516 - $28,523	-347 Reduced 45.01%	424 $35,000
Q1 2019 Apr 19, 2019	BUY	$45.83 - $70.54 $35,334 - $54,386	771 New	771 $54,000

211

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $986M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.